These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27848923)

  • 1. Immunoanalytical characteristics of unconjugated estriol: indications and analytical performances.
    Lefevre C; Gruchy N; Guénet D; Renom G; Allouche S; Read MH
    Ann Biol Clin (Paris); 2016 Dec; 74(6):717-723. PubMed ID: 27848923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome.
    Bestwick JP; Huttly WJ; Wald NJ
    Prenat Diagn; 2012 Mar; 32(3):299-301. PubMed ID: 22430732
    [No Abstract]   [Full Text] [Related]  

  • 3. Maternal serum Down syndrome screening: unconjugated estriol is not useful.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ; Sunderji SG; Larsen JW
    Am J Obstet Gynecol; 1990 Mar; 162(3):672-3. PubMed ID: 2138414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of monoclonal antibodies to estriol and their application in the development of a sensitive nonisotopic immunoassay.
    Ghosh SK
    Steroids; 1988; 52(1-2):1-14. PubMed ID: 3073543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoassay of unconjugated estriol in serum of pregnant women monitored by chemiluminescence.
    Klingler W; Haupt O; von Postel G; Knuppen R
    Steroids; 1983 Aug; 42(2):123-36. PubMed ID: 6673182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ
    Obstet Gynecol; 1991 Jun; 77(6):963-5. PubMed ID: 1709482
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML; Wagner RM; Slotnick RN
    Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous enzyme immunoassay of estriol in picogram amounts.
    Ghosh M; Dhar TK; Ali E; Bachhawat BK
    Clin Chim Acta; 1983 Mar; 128(2-3):223-31. PubMed ID: 6851138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol.
    Olsen RN; Dunsmoor-Su R; Capurro D; McMahon K; Gravett MG
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):376-80. PubMed ID: 23777262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
    Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
    Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progesterone and unconjugated estriol in amniotic fluid and serum in diabetic patients during induction of labor].
    Gstöttner H; Hoffmann P; Steinbach C; Herter U
    Zentralbl Gynakol; 1983; 105(1):40-4. PubMed ID: 6829240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of medians generators for the calculation of MoM for the first-trimester Down syndrome maternal serum markers.
    Morin JF; Moineau MP; Richard-Girème A; Talon H
    Ann Biol Clin (Paris); 2016 Jun; 74(3):293-8. PubMed ID: 27237803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of analytical factors on second trimester risk estimations.
    Serdar MA; Tütüncü L; Olgun A; Haşimi A; Ozgurtaş T; Erbil MK
    Int J Gynaecol Obstet; 2006 Apr; 93(1):28-32. PubMed ID: 16530198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
    Palomaki GE; Knight GJ; Haddow JE; Canick JA; Wald NJ; Kennard A
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunoassay for small analytes with theoretical detection limits.
    Ohmura N; Lackie SJ; Saiki H
    Anal Chem; 2001 Jul; 73(14):3392-9. PubMed ID: 11476240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference in an unconjugated estriol assay causing a false negative integrated prenatal screening report.
    Dennis AW; Siu VM; Campagnolo C; Soldin SJ
    Prenat Diagn; 2010 Feb; 30(2):165-7. PubMed ID: 20020420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.